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ABSTRACT
Purpose: The purpose of this study was to determine the presence and degree of treatment
effects found for direct attention training on three individuals with idiopathic Parkinson’s disease
(PD) using the Attention Process Training, Third Edition (APT-III; Sohlberg & Mateer, 2010).
APT-III was designed for use with individuals who have sustained a traumatic brain injury
(TBI), and was selected for this study because of the similarities in cognitive deficits between
those with TBI and those with PD.
Methods: This study was designed as a phase 2, randomized baseline, A1-B-A2-A3
(baseline, treatment, post-treatment, and follow-up assessment), single-subject experimental
design. The study followed the APT-III protocol (Sohlberg & Mateer, 2010) to train attention
processes over the course of 6 weeks in two 60 minute sessions per week.
Results: Participants all displayed treatment effects in at least one attentional domain
following this study. Results of secondary outcome measures designed to quantify level of
impairment, activity, and participation were variable. All participants remained within functional
limits for working memory for healthy adults their age, and all reported making progress toward
functional goals.
Discussion: The results of this study suggest that direct attention training using APT-III
can improve attention in people with PD (PPD), and that these improvements can be generalized
to increase performance on activities of daily living and other functional activities. It also
suggests that PPD may benefit from future research investigating the use of APT-III.

vi

INTRODUCTION
Parkinson’s disease (PD) is both a chronic and progressive neurodegenerative disease
affecting motor control and cognition (Lai & Tsui, 2001). PD affects approximately 1% of the
world’s population, with over 1 million patients in the US today (Payne, 2014). Affecting both
men and women, PD is typically a disease of mid to late life with an average onset age between
50 and 60 years and an expected life span after onset of 15 years (Duffy, 2013; Payne, 2014).
Because of the profound toll PD has on patients and their caregivers, it is a disease that deserves
further research for effective treatment and management (Payne, 2014).
PD was first described in 1817 by British doctor James Parkinson, and since that time it
has been characterized by four movement disorders: tremor, rigidity, bradykinesia, and postural
instability (Toma & Mihancea, 2014). Tremor, or shaking of the muscles, typically appears in the
head, jaw, arms, hands, and legs (Payne, 2014). Rigidity refers to muscular stiffness throughout
the body, bradykinesia to a slowing of overall movement, and postural instability to impaired
balance and coordination (Payne, 2014). These motor characteristics were initially considered
the only true symptoms of PD, but these days cognitive impairments and their effects on the lives
of PPD are also recognized (Payne, 2014).
It’s been estimated that as much as 80% of those with Parkinson’s disease develop some
form of cognitive impairment (Altman & Troche, 2011). PD is primarily recognized as being
caused by a loss of dopamine producing cells within the substantia nigra of the basal ganglia, a
deep brain structure that works in concert with various cortical areas (Rommelfanger &
Weinshenker, 2007). These brain connections lead to an array of cognitive symptoms previously
thought uninvolved in PD, including executive function and working memory deficits
(Rommelfanger & Weinshenker, 2007; Zgaljardic, Borod, Foldi, Mattis, Gordon, Feigin &
1

Eidelberg, 2006). These deficits have also been linked to language impairments, including
decreased fluency and difficulty with syntax (Altman & Troche, 2011). Other non-motor
symptoms associated with PD include depression, apathy, anxiety, and sleep disturbances (Toma
& Mihancea, 2014).
The array of cognitive deficits present in PPD is very similar to those presented by
patients who have suffered traumatic brain injury (TBI), although the damage in TBI results
from trauma to the frontal lobe and diffuse axonal damage, as opposed to degeneration in the
basal ganglia (Calleo, Burrows, Levin, March, Lai & York, 2012; Gardner & Yaffe, 2015; Wong
& Hazrati, 2013). Computerized treatment programs such as Attention Process Training (APT)
software, and later APT-II and APT-III, developed by Sohlberg & Mateer are designed to help
rehabilitate attention and working memory deficits in TBI patients, and research supports the use
of these programs (Sohlberg & Mateer, 2010; Sohlberg & Mateer 2000; Sturm, 1997).
Given the similarities in cognitive deficits between those with TBI and those with PD, it
is worth investigating whether APT-III is an effective tool for treating those with PD. A
feasibility study has already been conducted and has shown that PPD are good candidates for
APT (Mohlman & Chazin, 2011). In her 2013 thesis, Ferguson demonstrated treatment efficacy
of APT-II in a single-subject case study. Her findings warrant further research to determine if the
APT-III would lead to similar results decreasing attention deficits in improving the cognitive
symptoms of PPD. This study will continue such investigations by looking at the effects APT-III
has on those with idiopathic PD, a group for whom no evidence-based cognitive treatments
currently exist (Calleo et al., 2012).
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CHAPTER 1. LITERATURE REVIEW
The following review assess literature covering the four key aspects of this study. These
include the neuropathology of PD, the cognitive deficits associated with it, current theories on
attention and memory, and the evidence behind the efficacy of APT training programs.
1.1 Neuropathology of Parkinson’s Disease
As stated above, PD is most widely attributed to a decrease in dopaminergic cells in the
substantia nigra of the basal ganglia (Payne, 2014). This is still held as true, especially in regards
to motor deficits, but some researchers have suggested more complex causes of these symptoms
(Rommelfanger & Weinshenker, 2007). In their 2007 review, Rommelfanger & Weinshenker
discussed a number of findings suggesting that the locus coerulius and its decreased production
of norepinephrine played a substantial role in both motor and cognitive deficits of PD. While
these findings are interesting, most theories about the cause of both motor and cognitive
symptoms of PD center around the basal ganglia structures and their relationships with other
cortical brain structures (Weber, 1990). The basal ganglia is a deep brain structure comprised of
a group of cell nuclei located within the cerebral hemispheres (Weber, 1990). These nuclei are
referred to individually as the caudate nucleus, the putamen, the globus pallidus, the subthalamic
nucleus, and the substantia nigra (Nieoullon, 2002; Weber, 1995; Zgaljardic et al., 2006). They
work closely with one another and the thalamus to communicate with cortical brain structures
that influence movement and cognition (Weber, 1990).
Initially researchers were puzzled by the way PD cognitive symptoms mirrored those
associated with dysfunction in unrelated brain structures, such as the frontal lobe (Nieoullon,
2002; Zgaljardic et al., 2006). A combination of human and animal studies investigating the
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individual relationships the basal ganglia and cerebellum have with the cortex served to
determine that communication loops exist that allow for complex interaction between these deep
brain and cortical structures (Middleton & Strick, 2000).
The interactive relationships of the basal ganglia with frontal lobe structures appear to be
the source of cognitive problems in PD (Nieoullon, 2002; Owen, 2004; Zgaljardic et al., 2006).
These complex relationships are referred to as frontostriatal loops and they are recognized for
carrying information between the basal ganglia and the frontal lobe via the thalamus (Zgaljardic
et al., 2006). Other frontostriatal loops associated with cognitive function include the
dorsolateral prefrontal cortex (DLPFC), the anterior cingulate cortex (ACC), and the
orbitofrontal cortex (OFC), and each is associated with a different cognitive process (Nieoullon,
2002; Owen, 2004; Zgaljardic et al., 2006; Weber, 1990). The DLPFC is responsible for
regulating the executive functions of cognition, the AAC with attention processes, and the OFC
with decision making, impulse control, perseveration, and mood (Middleton & Strick, 2000;
Zgaljardic et al., 2006). These loops and their roles in cognitive processing provide insight as to
why what was previously thought of as localized basal ganglia damage in PD affects cognitive
processes associated with other brain areas.
1.2 Cognitive Deficits in Parkinson’s Disease
Cognitive problems in PD frequently occur early on in the disease as mild cognitive
impairment (MCI), and later in the disease as dementia (Toma & Mihancea, 2014). According to
Toma & Mihancea (2014), approximately one third of newly diagnosed PPD meet the criteria for
MCI, and five years after onset this number increases to 50%. A 2014 study by Gerrits, van der
Werf, Hofman, Foncke, Berendse, & van den Heuvel pointed to gray matter volume as a possible
explanation for the variation in cognitive abilities among PPD. His results showed a positive
4

correlation between decreased gray matter in specific brain areas and poor performance on
related cognitive tasks for PD patients presenting with and without cognitive impairment (Gerrits
et al.).
Cognitive deficits associated with PD affect many domains. Executive function and
working memory are typically affected first, followed by memory, visuospatial skills, and
concept formation (Altman & Troche, 2011; Nieoullon, 2002). For working memory, it has been
found that tasks requiring some form of manipulation tend to be more impaired than those that
require the more basic processes of storage and updating information (Altman & Troche, 2011).
Impairments of executive function in PD include anticipation, planning, initiation, inhibitory
processing, and switching between tasks and sets (Nieoullon, 2002; Owen, 2004; Zgaljardic et
al., 2006). Impairments of working memory and executive function have been related to
language problems in PD, as these functions underlie the complex task of language formation
and use (Cummings, Darkins, Mendez, Hill & Benson, 1988). For example, Crosson (1985)
found that early impairment of thalamic, putamen, and caudate function in PD were associated
with DLPFC trouble during language production, including the DLPFC portion covering Broca’s
area. The frontostriatal loops responsible for set switching and inhibition in particular are thought
to affect both language and cognition (Ali, Green, Kherif, Devlin, & Price, 2010). Research has
also suggested that lesions in these networks caused by PD can affect how well information is
processed, leading to symptoms of impaired fluency and grammatical deficits (Kolk, 1995).
Considering the neuronal connectivity between the basal ganglia and frontal lobe
structures, it is understandable that some cognitive symptoms of PD mirror those of frontal lobe
damage (Calleo et al., 2012). Specifically, frontal lobe damage shares many of the same
executive functions and memory deficits as early forms of PD (Nieoullon, 2002; Owen, 2004;
5

Zgaljardic et al., 2006). For example, in 1989 Stuss, Stethem, Hugenholtz, Picton, Pivik &
Richard identified deficits in information processing, divided attention, and focused attention in
patients with TBI. Similarly, McNab & Klingberg in 2007 identified a similar frontostriatal loop
regulating working memory to those regulating attention. Because of these similarities, and
because some Parkinson’s-like symptoms are caused by brain injury in the form of encephalitis,
researchers have been investigating a possible causal relationship between other forms of TBI
and the development of idiopathic PD (Payne, 2014;Wong & Hazrati, 2013). While results of
these studies are largely inconclusive, they do attest to the degree of overlap among symptoms
found in both disorders and suggest that using evidenced-based TBI treatments for PPD could be
promising (Gardner & Yaffe, 2015; Wong & Hazrati, 2013).
1.3 Attention and Working Memory
A clinical model of attention that has been widely accepted and led to the creation of
Attention Process Training (APT), a therapy program designed for individuals with TBI, is that
of Sohlberg and Mateer. Their original framework divided attentional domains into focused,
sustained, selective, alternating, and divided attention (Sohlberg & Mateer, 1987). Focused
attention was considered a low-level ability to respond to specific stimuli; selective attention, the
ability to activate and inhibit automatic responses while discriminating between stimuli;
alternating attention, the ability to move between tasks with different cognitive requirements;
and divided attention, the ability to manage multiple tasks at the same time (Sohlberg & Mateer,
1987). In this model, sustained attention was comprised of working memory, or the ability to
keep information in mind while manipulating it, and vigilance, or the ability to maintain focus
during a repetitive task (Kimbarow, 2016; Sohlberg & Mateer, 1987).
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The 2010 revision of Sohlberg and Mateer’s model reflects changes in the perceived roles
of executive control, working memory, and divided attention (Kimbarow, 2016). Currently their
model holds that executive control is comprised of the distinct subcategories of working
memory, sustained attention, selective attention, suppression, and alternating attention which has
subsumed the former category of divided attention (Kimbarow, 2016; Sohlberg & Mateer, 2010).
While it is clear that there is a relationship between attention and working memory, the
cause of this relationship has not always been understood (McNab & Klingberg, 2008). In
studies utilizing fMRI imaging, results have shown that not only is working memory likely
controlled via a frontostriatal loop similar to those that control attention, but that dopamine plays
a role in working memory also (McNab & Klingberg, 2008). Particularly, the globus pallidus of
the basal ganglia is associated with working memory. This area, along with the frontal lobe, has
been found to activate when filtering of irrelevant stimuli is completed prior to memory encoding
(McNab & Klingberg, 2008). These findings point to attention as a closely related prerequisite to
working memory function.
1.4 Attention Process Training
Despite the research indicating the presence of cognitive deficits in PPD, there is little
research specifically addressing treatment of these deficits. However, a body of research exists
showing the value of training specific attention domains in TBI patients which may provide a
bridge to treating these deficits in PPD. Most of these studies specifically address APT and have
looked at its use among patients who have suffered brain injury due to both vascular and bluntforce origin.
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In a 1997 study that did not look at APT but rather another computer program, Sturm,
Willmes & Orgass showed that training specific attentional deficits via computer software was
an effective way to improve patient performance. The study involved 38 subjects with right or
left vascular brain injuries and looked specifically at alertness, vigilance, selective, and divided
attention (Sturm et al.). His results showed a positive training effect for tonic alertness and
vigilance as well as reduced response times for alertness and selective attention tasks (Sturm,
1997).
In 2000 Sohlberg and Mateer tested their APT program on a group of 14 TBI patients
who demonstrated attention and memory deficits. Their study utilized a cross-over design that
gave patients 10 weeks of APT and 10 weeks of brain injury education which included
supportive listening and relaxation training (Sohlberg & Mateer). Their results showed a number
of things, including that practice was the best source of improvement for both treatments
(Sohlberg & Mateer). They also found better improvement after each session for the APT group
compared to the brain injury education group, as measured by results on the Paced Auditory
Serial Addition Task (PASAT) (Gronwell, 1977), a measure of attention (Sohlberg & Mateer).
For working memory, both groups showed similar improvement results with the exception of
working memory for location, which was proven to be better for the APT group (Sohlberg &
Mateer).
In 2006 Pero, Incoccia, Caracciolo, Zoccolotti, & Formisano, looked at the effects of
training two TBI patients with the APT program. Both patients’ injuries resulted from vehicular
accidents (Pero et al., 2006). From pre-test to post-test, one patient showed an increased ability
to manage dual task stimulation while the other showed improvement on vigilance, selective
attention, and divided attention (Pero et al., 2006). In a 2009 randomized clinical trial, Barker8

Collo, Feigin, Lawes, Parag, Senior, and Rodgers compared the effects of APT training versus a
standard care program in 78 stroke patients. Results showed an improvement at 6 months poststroke in auditory and visual effects of attention as measured by the Integral Visual Auditory
Continuous Performance Test (IVA-CPT) (Barker-Callo, et al.).
Only one published study to date has investigated the use of APT on PPD, and this study
addressed feasibility of treatment rather than treatment effects. Mohlman and Chazin’s 2011
feasibility study investigated how well 16 PPD with no signs of dementia could manage using
the APT-II program (Sohlberg & Mateer, 2001). The study measured patient fatigue, effort,
progress and enjoyment in participating in four, 90 minute training sessions over the course of a
month (Mohlman & Chazin). Results indicated that tasks required moderate to high levels of
effort from patients, but that patients enjoyed the treatment and were able to successfully
complete it (Mohlman & Chazin). These results held true in light of the fact that alternating and
selective attention tasks produced considerable fatigue (Mohlman & Chazin). Despite this,
patients made improvements in these domains (Mohlman & Chazin).
In her 2013 unpublished thesis, Ferguson investigated treatment efficacy of APT-II on
one patient with PD. Her multiple baseline single-subject study consisted of one, 2 hour
treatment session per week for a total of 6 weeks (Ferguson). Results showed improvement in
sustained attention for percent accuracy and timed performance, as well as improvements for
percent accuracy and timed performance in selective and divided attention, two domains that
were not specifically targeted in treatment (Ferguson).
Given the positive results of Ferguson’s study and the proven feasibility of treating PPD
with APT, we wished to further investigate the effects of APT training on individuals with
idiopathic PD. This study aimed to replicate the results of Ferguson’s study using a larger sample
9

size. Since the Ferguson study the APT-III has become available. It is computerized and does not
require participants to complete paper-pencil tasks. To alleviate the possible difficulty paperpencil tasks might cause participants with PD, we chose to use the APT-III. We hypothesized
that we would see positive effects for APT-III training, and that these results would also be
apparent on measures of functional attention and working memory. This study asked the
following experimental questions:
1. What is the treatment effect of APT-III when given to participants with PD and
attention deficits over the course of 6 weeks in two 60-minute sessions per week?
2. What improvements are shown in the following three measures of attention deficits
and functional attention: Continuous Performance Test (CPT-II) (Connors, 2004), Test of
Everyday Attention (TEA) (Robertson, Ward, Ridgeway & Nimmo-Smith, 1994), and
APT-II Attention Questionnaire (Sohlberg, Johnson, Paule, Raskin & Mateer, 2001)?
3. What changes of working memory are shown on automated working memory tasks
Size Judgment Span task (Cherry, Elliot, & Reese, 2007) following APT-III treatment?
4. What evidence of generalization of training on APT-III is demonstrated by progress on
functional goals?
If positive, the results of this study would provide evidence for the use of APT-III in the
treatment of attention and working memory deficits in PPD.
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CHAPTER 2. METHODS
2.1 Design
This study was designed as a phase 2, randomized baseline, A1-B-A2-A3 (baseline,
treatment, post-treatment, and follow-up assessment), single-subject experimental design
(SCED). Rehabilitation scientists have advocated for the systematic study of treatment efficacy
using small N or single-subject-designed studies such as this one (Robey, 2004; Rodriguez &
Gonzalez-Rothi, 2008). These early phase studies allow the investigator not only to establish
treatment efficacy, but also to identify optimal treatment participants and refine the treatment
protocol as needed. The study was approved by the Louisiana State University Institutional
Review Board. The participant received informed consent prior to starting the study.
2.2 Participants
Three PPD were recruited from local PD support groups. Participants met the following
inclusion criteria: PD as diagnosed by a physician, a Hoehn & Yahr PD Severity Rating of 1-3
(Hoehn & Yahr, 1967), no other prior or existing neurological or neurodegenerative diseases, no
language disorders, no dementia as measured by the Montreal Cognitive Assessment (MoCA)
(Nasreddine, 2015), no depression as measured by the Geriatric Depression Scale (GDS) Short
Form (Sheikh & Yesavage, 1986), no apathy as measured by The Lille Apathy Rating Scale
(Sockeel, Dujardin, Devos, Deneve & Defebvre, 2006), a minimum high school education,
vision deemed adequate based on the results of the Rosenbaum Pocket Vision Screener, hearing
deemed adequate based on conversation and following directions in the testing environment, a
stable cycle of PD medications, at least one attention deficit as identified on the APT-II Attention
Questionnaire (Sohlberg et al., 2001). All particiapnts were considered ideal at the time of pre-
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treatment having met all inclusion criteria. Participants were also roughly similar across age,
level of education, Hoehn & Yahr severity scores, and scores on the screening measures used to
qualify them for the study. Participants included one male and two females. Table 1 summarizes
participant characteristics and screening results.
Table 1. Participant characteristics and screening results
Participant Sex

Age

Occupation

101

M

72

Years Years
H & Y MoCa LARS M.F.
with of Ed.
PD
Professional
6
16
2
25
-20 18.5

102

F

70

Professional

10

16

3

25

-35

14.5

103

F

69

Professional

11

18

3

25

-30

22

Note: H & Y = Hoehn and Yahr (1967), MoCa = Montreal Cognitive Assessment (Nasreddine et
al., 2015), LARS = Lille Apathy Rating Scale (Sockeel et al., 2006), M.F. = Mental Fatigue
(Johansson & Ronnback, 2014)
2.3 Outcome Measures
The primary outcome measures were the percent accuracy of treatment probes given at
the end of each session. The most difficult task for each APT-III attention domain was used to
develop treatment probes. Ten sets of 10 randomly selected items from each domain were
developed and used as probes which were randomly administered to obtain baselines, measure
treatment after each session, and determine post-treatment and follow-up results. Selected probes
were randomized to prevent learning bias.
Valid and reliable secondary outcome measures were chosen to measure attention
impairment, functional attention, self-reported attention problems; and working memory (as were
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done in previous APT-III research). The investigator used pre-treatment test results to determine
appropriate attention exercises for treatment, help establish functional goals and aid in selection
and training of metacognitive strategies.
These measures were also chosen to assess the various domains of the World Health
Organization ICF since the American Speech-Language-Hearing Association Scope of Practice
requires that speech language pathologists assess and treat communication disorders across the
ICF domains of impairment, activity and participation (American Speech-Language-Hearing
Association, 2016). The CPT-II was selected to measure impairment. The CPT-II defines
inattention as t-scores greater than 60. Participants each received a clinical impairment score
which placed over 100 indicates the percent chance that a “significant attention problem exists”
(Conners, 2004).
The TEA was selected to measure the ICF activity domain. Results from the TEA
generate scaled scores with a mean of 10 and a standard deviation of +/-3. The TEA measures
visual selective attention, alternating attention, sustained attention and auditory visual working
memory using a number of subtests. Map Search and Telephone subtests factor into visual
selective attention; the Visual Elevator subtest correspondes to alternating attention; the Lottery,
Elevator Counting, and Telephone Search subtests correspond to sustained attention; and the
Elevator Counting and Elevator Counting with Distractors subtests correspond to auditory and
visual working memory (Robertson, Ward, Ridgeway & Nimmo-Smith, 1994).
The APT-II Attention Questionnaire was given to generate a self-reported measure of
participation in accordance with the ICF. Results of the APT-II Attention Questionnaire rate how
much the participant perceives attention deficits to interfere with activies of daily living (ADLs).
The APT-II Attention Questionnaire generates scores that correspond to the following ratings
13

and their disruption of ADLs: little-mild disruption, moderate disruption, severe disruption, and
profound disruption.
The Size Judgment Span (SJS) task, selected to measure working memory for this older
population, has established validity and reliability for a range of ages, education levels and
occupations (K. E. Cherry & Park, 1993). Researchers have also reported that the SJS task has
demonstrated validity and reliability for even the oldest old (K. Cherry, Elliott, & Reese, 2007),
which would suggest that it could be useful for PPD. The SJS task requires participants to
rearrange stimulus items in accordance to their size; for example, if given “football-tadpole,” the
correct response would be “tadpole-football.” The task becomes increasingly difficult as the
stimulus size increases. Because the SJS task contains elements of verbal and visuospatial
processing, the participant can take different approaches to complete SJS tasks; this is what
makes SJS a useful tool for assessing WM (Cherry et al., 2007). However, SJS has not been used
in the PD literature as a measure of WM. The SJS has a mean of 3.53 and a standard deviation of
72 for individuals from 64 to 74 years of age (K. Cherry et al., 2007).
2.4 Procedures
The study was primarily conducted in the LSU Department of Communication Sciences
and Disorders therapy rooms. When participants were not able to come to LSU due to
transportation difficulties, the research assistant and/or investigator traveled to their homes to
render treatment or gather assessment data. In both locations, all probes and treatments were
administered in a quiet room free from distractions. The investigator recruited, screened, and
assessed participants for the study. To ensure blinding of participant type and severity of
attention deficits, the research assistant administered the APT-III. The three participants were
enrolled in the study sequentially with the first participant receiving 5 baseline probes to
14

establish stable initial performance. Participant 2 received 8 baseline probes, and participant 3
received 12 baseline probes. The number of probes assigned to each participant was determined
by random number generating software and the stabilization of baseline probes.
Treatment followed the APT-III protocol, which calls for the use of specific attention
exercises based on the participants’ functional level in the different attentional domains; the
identification, training, and review of applicable metacognitive strategies; and the identification
and review of functional goals and generalization activities through Goal Attainment Scaling
(GAS) (Sohlberg & Mateer, 2010). Refer to Appendix B for example metacognitive strategies
and Appendix C for examples of goals addressed through GAS. Following is an outline of the
procedures for each treatment phase.
A1-Baseline Phase: The CPT-II, TEA, and the APT-II Attention Questionnaire (Sohlberg
et al., 2001) were administered to assess pre-treatment attention. The Size Judgment Span task
(Cherry et al., 2007) was given to assess working memory. Ten sets of probe questions with 10
randomly selected tasks from each training domain were developed. One set was administered
for each baseline and at the end of each treatment. With the exception of participant 3, they were
randomly presented to participants to eliminate the learning effect. For participant 3, working
memory probes were presented last in the majority of treatment and post-treatment sessions to
reduce the level of participant distraction caused by switching between computer-based probes
and the auditory-based working memory probes. The attentional probes were still presented in
random order. Descriptions of probes can be found in Appendix A.
B-Treatment Phase: Each participant received 12 total hours of treatment delivered in
two, 60-minute treatment sessions over 6 weeks following the APT-III protocol. For each
participant, treatment began at the point where attention deficits were detected in the initial
15

assessment. The APT-III attention domains include sustained attention and executive control
with the subdomains of working memory, selective attention, suppression, and alternating
attention. The APT-III protocol does not standardize mastery; the investigator initially set the
criteria for moving to the next harder task at 80% accuracy for 3 trials and criteria for decreasing
complexity at 50% or lower accuracy for 2 trials. It became clear in treatment, however, that this
criteria led to excessive task repetition which in turn led to frustration and demotivation of
participants. To maintain participant morale and prevent unnecessary redundancy, the research
assistant followed the direction of the APT-III manual which encourages the use of clinician
judgment when increasing complexity of attentional tasks.
Prior to beginning APT-III training, the participants and research assistant used goal
attainment scaling (GAS) to identify functional goals that each client wanted to achieve as
treatment progressed. Examples of functional goals for the different areas of attention can be
found in Appendix C. Participants were given a log to monitor their progress toward goals and
briefly discussed their progress with the research assistance prior to beginning treatment each
session.
For each treatment session, results were recorded on score sheets provided in the APT-III
program to help identify error patterns and monitor the effectiveness of metacognitive strategy
use. Score sheets identify both participant progress over time and a detailed picture of
performance on the five most recent attempts at a specific task. At the beginning of each session,
participants discussed with the research assistant the use of metacognitive strategies to be applied
in that treatment session. Metacognitive strategies are self-management practices that help
individuals assess and adjust their behavior to better function on a task or in a certain
environment. These strategies were included in training to help participants compensate for their
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attentional deficts on APT-III tasks and also to help them compensate outside of the clinic
setting. Examples of metacognitive strategies can be found in Appendix B.
A2-Post-treatment Phase: The research assistant collected three treatment probes in the
sessions following the completion of the treatment. Post-treatment assessments were conducted
by the investigator and included the CPT-II, the TEA, the Attention Process Training-2
Questionnaire, and the SJS task.
A3-Follow-up Phase: Approximately 30 days after the completion of post-treatment
testing, participants returned to LSU for follow-up assessments which again included the
secondary outcome measures detailed above as well as three baseline measures.
2.5 Reliability and Treatment Fidelity
The investigator observed 15 minutes of every 4th session, post-session debriefing, and
problem solving discussion to ensure treatment fidelity. Inter-rater reliability was not addressed
because probe data was collected and scored via computer program, precluding human error.
Intra-rater reliability was addressed by double checking that all data was transferred accurately
from the computer program to the research assistant’s data log for analysis.
2.6 Data Analysis
This study utilized a combination of visual analysis traditionally used in single-case
research and one statistical analysis to determine effect size (Kratochwill et al., 2010; Olive &
Franco, 2008). For the visual analysis, three judges who were not familiar with the study were
asked to inspect the plotted data from baseline to post-treatment, and treatment
withdrawal/follow-up and to decide whether or not performance had improved (Kratochwill et
al., 2010; McReynolds & Kearns, 1983). The statistical analysis was completed using standard
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mean difference (SDM) to calculate effect size (Olive & Franco, 2008). SDM is calculated using
the formula below. Once a value was found for d, it was interpreted using Cohen’s measure of
effect size, where 0.2 represents a small effect, 0.5 represents a moderate effect, and 0.8
represents a large effect (Cohen, 1988). Using the Cohen’s d interpretation of effect size has
become an accepted practice in single subject design when there is not enough evidence to
establish a treatment’s effect size (Olive & Franco, 2008). The formula used for calculating
effect size using standard mean difference was as follows: d = MA1 – MA2/SDA1, where MA2 is
the mean of post-treatment probes, MA1 is the mean of baseline probes, and SDA1 is the standard
deviation of baseline probes.
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CHAPTER 3. RESULTS
This study asked the following experimental questions:
1. What is the treatment effect of APT-III when given to participants with PD and
attention deficits over the course of 6 weeks in two 60-minute sessions per week?
2. What improvements are shown in the following three measures of attention deficits
and functional attention: Continuous Performance Test (CPT-II) (Connors, 2004), Test of
Everyday Attention (TEA) (Robertson, Ward, Ridgeway & Nimmo-Smith, 1994), and
APT-II Attention Questionnaire (Sohlberg et al., 2001)?
3. What changes of working memory are shown on automated working memory tasks in
the Size Judgment Span task (Cherry et al., 2007) following APT-III treatment?
4. What evidence of generalization of training on APT-III is demonstrated by progress on
functional goals?
To answer Q1, primary outcome meaures included probe exercises completed at the end
of each treatment session. To answer Q2, secondary outcome measures including the CPT-II,
TEA, APT-II Questionnaire were taken. For Q3, the SJS task was measured. The investigators
used these measures, along with baseline probe scores to establish a baseline, determine
appropriate attention exercises for treatment, establish goals, and design and facilitiate
metacognitive strategies. In addition to answering Q4, progress on functional goals was reported.
Answers to the experimental questions are presented below by participant.
All participants completed the planned 6 week treatment, its post-treatment assessment
sessions, and 1 month follow-up sessions. Results for all domains were analyzed using visual

19

analysis and effect size calculations. Visual analysis graphs are shown for each participant in
Figures 1, 2, and 3.
The graph for the trained domain is pictured first followed by the probes for untrained
domains. Each graph shows percent accuracy on the vertical axis and the session number on the
horizontal axis. For the treated domain, data points labeled with a B indicate baseline measures,
those with a T indicate treatment sessions, those with a P indicate post-treatment, and those with
an F indicate follow-up. In some cases, vertical axes vary in scaling as a reflection of
differences in percent accuracy obtained. Judges were first asked whether baseline measures
were stable, and then asked to identify the trend of treatment probes, post-treatment probes, and
follow-up probes. Effect sizes were calculated for both 1 week post-treatment assessment and 1
month follow-up assessment and are detailed in below in Table 2. The trained domain for each
participant appears in the first column.
3.1 Participant 1
Q1. Participant 1 completed sustained attention tasks during the treatment phase. His
treatment did not target selective attention, working memory, suppression, nor alternating
attention. However, these domains were probed continuously throughout the study in the event
that treatment could progress to the next domain, and to observe whether changes in the treated
domain (sustianed attention) led to improvement in other domains. Participant 1 used a number
of metacognitive strategies that included specifically identifying aspects of the task that were
easy and/or difficult, predicting easy or difficult task components before beginning training on a
new task, and repeating instructions to himself prior to beginning a task to ensure
comprehension.
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Figure 1. Particpant 1 visual analysis graphs
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Figure 2. Participant 2 visual anlysis graphs
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Table 2. Effect sizes comparing pre-treatment to post-treatment and follow-up for all participants

PostTx
Follow
-up

Post
Tx
Follow
-up

Post
Tx
Follow
-up

Sustained
Attention
-1.534

Selective
Attention
-0.333

-0.045

-0.667

Sustained
Attention
-0.991

Selective
Attention
-1.179

0.115

-0.236

Selective
Attention
-0.246

Sustained
Attention
-0.686

-1.138

-0.394

Participant 1
Working
Memory
1.20
3.867
Participant 2
Working
Memory
-0.032
0.224
Participant 3
Working
Memory
0.533
0.311

Suppression
3.083

Alternating
Attention
0.526

5.834

0.388

Suppression
-1.048

Alternating
Attention
-0.115

-2.644

-0.484

Suppression
0.441

Alternating
Attention
-0.474

1.544

-0.869

All three judges agreed that participant 1 had stable baselines in his treated domain prior
to commencing the APT-III. While judges 1 & 2 agreed that there was no change for this domain
in the A1-A2 phase, judge 3 saw a modest improvement. All judges agreed that improvement
occurred between the A2-A3 phases. For selective attention, all agreed that between the A1-A2
and A2-A3 phases, there was no change in performance. Working memory was judged improved
between A1-A3, and suppression between A1-A2 and A1-A3. For alternating attention, judges
agreed that improvement occurred between A1-A3. See Figure 1.
Effect size calcuclations showed a decrease in performance in the results between A1-A2
and A1-A3 analyses for sustained attention, most likely due to the variability on probe task
performance throughout training, although the participant progressed from simple to more
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complex APT-III computerized tasks. For the untrained attention domains, working memory and
supression improved significantly, as evidenced by the large effect sizes indicated at both posttreatment and follow-up. See Table 2. Results for the alternating attention domain maintained a
small to medium increase from post-treatment to follow-up. Selective attention performance
declined between post-treatment and follow-up, with a negative small and then negative medium
effect size. In summary, for particpant 1, a treatment effect was demonstrated for the untrained
domains of working memory, suppression, and alternating attention.
Q2. At pre-treatment, particpant 1 had a CPT-II clinical profile score of 50, indicating
that there was 50/100 chance that a significant attentional deficit was present. All other CPT-II
attentional categories for particpant 1 were consisdered within normal limits. At post-testing,
partipant 1’s CPT-II clinical impairment score remained at 50. His score for response style had
improved to the mildly atypical level. Scores for omissions had dropped to the level of
inattention with the t-score increasing from 46.05 to 61.43. Hit reaction time also dropped to the
category of inattention, but only by a small interval from 57.68 to 58.48. All other scores
remained the same. At follow-up, clinical impairment score remained at 50. Response style
continued to improve to the normal range, and omissions had returned to normal limits, dropping
in t-score from 61.43 to 42.97. Hit reaction time remained about the same with a t-score of 58.34,
down from 58.48. Hit reaction time standard error, however, dropped from t-score 55.13 to
49.07, moving particpant 1 back to the level of inattention. Refer to Appendix D for all
secondary outcome results.
For the TEA, results indicated deficits of 1 SD or more in the following domains:
selective attention and divided attention. On the TEA, participant 1 remained at the mean (10)
for Elevator Counting at both post-treatment and follow-up. His scores for Lottery remained
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within one SD above or below the mean from A1-A2-A3. Both Elevator Counting and Lottery
correlate to sustained attention and these results show that particpant 1’s sustained attention
abilities remained steady throughout treatment. Scores for the Map Search decreased steadily
from A1-A2-A3, going from 6 at pre-treatment to 3 at follow-up, suggesting that paritcpant 1
experienced a drop in selective attention abilities. On the contrary, Telephone Search results
went from 5 at A1 to 4 at A2 to 9 at A3 which suggest an increase in selective attention abilities.
Elevator Couting with Distractors went from 13 in A1 to 5 in A2 to 10 in A3 indicating a dip at
post-treatment in selective attention and working memory. The Telephone Search Counting
scores went from 2 at A1 to 6 at A2 back to 2 at A3, indicating variable performance in alternating
attention.
Pre-treatment results of the APT-II Attention Questionnaire indicated a severe effect of
attentional deficits on ADLs. Scores improved consistently from pre-treament to post-treatment
and follow-up. His initial score of 32 indicated a severe attentional disruption to ADLs while his
post-treatment score of 17 indicated moderate disruption. His follow-up score of 12
demonstrated further improvement to the level of little-mild disruption.
Q3. On the SJS, improvement was seen for particpant 1 from pre-treatment to posttreatment and this improvement remained at follow-up. Particpant 1 scored 3 at pre-treatment,
which is less than 1 SD below the mean. At post-treatment and again at follow-up, participant 1
scored 4. Refer to Appendix D for all results.
Q4. Participant 1 initially identified 2 separate functional goals to be addressed in
treatment. The first was recalling where he’d placed his keys and the second was remembering
where he’d placed his eyeglasses. By mid-treatment participant 1 was effectively using a system
of putting these items in specific places and, when unable to do so, taking a moment to commit
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to memory exactly where he was placing them and why. New goals were discussed mid-semester
and after taking into account feedback from his spouse, participant 1 agreed to add the goal of
maintaining a conversational topic for 7 minutes at a time. Participant 1 appeared less concerned
about this goal than the previous two, and provided less reliable feedback on his progress
throughout the remainder of treatment. It appeared that because participant 1 maintained his rich,
pre-morbid social life, he didn’t see his conversational abilities as affected by his attention,
despite the reports of his spouse.
Regardless, participant 1’s self-report indicated that his progress on this goal was
satisfactory. During week 5 and 6 of treatment, he repeatedly reported being able to stay on topic
in group and one on one conversations for 8-10 minutes at a time, although he did admit that he
may not have realized every time he drifted off topic. In contrast, the initial two goals of
recalling where participant 1 had placed his eyeglasses were inarguably met by the fourth week
of treatment. Refer to Table 3 below for participant 1’s goals and outcomes.
Table 3. Participant 1 summary of functional goal progress
Functional Goal
1. Participant will recall
where keys were last
placed by using key hook
every time he enters the
house. If he cannot put
keys on the hook, he will
repeat to himself where
he is placing keys before
walking away.

Pre-treatment Rating and
Interpretation
-2
Able to recall where he
placed keys 70% or less of
the time over the course of a
week and not using
repetition strategy.
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Post-treatment Rating and
Interpretation
+1
Able to recall where he
placed his keys 90% of the
time or more over the
course of a week with
repetition strategy.

Table 3. continued
Functional Goal
2. Participant will recall
where he placed his
glasses by repeating to
himself where he is
placing them before
walking away
3. Participant will maintain
the topic in a 7 minute
conversation by cueing
self to “tune in” and ask
for clarification as
needed.

Pre-treatment Rating and
Interpretation
-2
Able to find glasses less
than 60% of the time over
the course of a week and
not using repetition strategy.

Post-treatment Rating and
Interpretation
+1
Able to find glasses 80% or
more of the time over the
course of a week with
repetition strategy.

-2
Able to maintain topic in a
3 minute conversation but
will forget to “tune in” or
by asking for clarification.

+1
Able to maintain topic in a
10 minute conversation by
cueing self to “tune in” or
by asking for clarification
when needed.

3.2 Particpant 2
Q1. Participant 2 followed the same schedule described above for participant 1. She was
given both a slow and fast version of each task and was required to achieve a score of 80% or
higher to proceed to the next task. On tasks in which she excelled, this meant that as few as 2
trials at 80% were required to move on. For the most part, criteria was met at the initial
presentation of slow speed, not met at the initial presentation at the fast speed, but met
immediately afterward on the second presentation at the fast speed. In these cases, participant 2
was still allowed to proceed to the next task. Similarly for decreasing complexity, participant 2
reverted back to the previously mastered task after achieving two consecutive scores below 80%
accuracy, rather than training the same task indefinitely. Participant 2 also used a number of
metacognitive strategies to improve her performance, including identifying aspects of the task
that were easy and/or difficult; predicting easy or difficult task components before beginning
training on a new task, and repeating instructions to herself prior to beginning a task to ensure
comprehension. She also utilized breathing and postural techniques which included taking 10
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deep breaths before beginning training on APT-III tasks, using “body alert” posture (an APT-III
term) which involved sitting comfortably with a straight back and with the body oriented directly
forward toward the computer screen. The deep breathing strategy proved so useful that the
Participant 2 often employed it before commencing treatment probes at the end of each session.
It should be noted that participant 2 commenced treatment after 8 baseline measures were
taken but before her baseline for sustained attention had stabilized. However, treatment probe
results for sustained attention following her initial treatment session decreased by 10%,
indicating that no learning effect had occurred. Two judges did not consider participant 2 as
having a stable baseline in her treated domain, sustained attention, prior to treatment. Judges 1
and 2 saw improvement between A1-A2 and all three judges saw improvement between A1-A3.
Selective attention was ruled as improved between A2-A3 and working memory was ruled by
judges 2 and 3 as decreasing between A2-A3. All judges saw a decreasing trend for suppression
between A1-A3. No agreement was found for alternating attention. Below are the graphs used
during visual analysis. See Figure 2.
Most notably for participant 2 is the across the board decrease in performance for each
domain at the post-treatment assessment. Sustained attention showed a small improvement at
follow-up. A similar trend was seen for working memory, where a decrease in performance at
post-treatment became a small improvement at follow-up. In summary for participant 2, small
improvement occurred at follow-up for the trained domain of sustained attention and the
untrained domain of working memory. See Table 2.
Q2. Pre-treatment results of the CPT-II indicate a CI score of 55.54, meaning there was a
55.54/100 chance that a significant attention impairment was present. Other CPT-II pretreatment results showed inattetion in the categories of omission, hit reaction time, hit reaction
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standard error, and variability. Response style was rated as markedly atypical and perseverations
indicated impulsivity. At post-treatment, participant 2 had increased her CI score to 57.13 and at
follow-up she increased it again more dramatically to 73.39, well beyond the cutoff of CI score
60 for a severe attentional imapirment. CPT-II post-treatment results indicated improvement in
omissions from inattention to normal limits and improvement in variability from inattention to
normal limits. Response style had improved from markedly atypical to mildly atypical, and
preseverations had improved from impulsive to normal limits. Hit reaction time and hit reaction
time standard error remained unchanged. These results remained largely unchanged at follow-up
with the exceptions of hit reaction time block change and hit standard error block change. Both
of these categories fell from within normal limits to poor vigilence. T-scores scores for hit
reaction time block change increased from 50.58 at post-treatment to 60.1 at follow-up and from
46.45 at post-treatment to 58.1 at follow-up for hit standard error block change. Refer to
Appendix D for all secondary outcome results.
Pre-treatment TEA results indicated that participant 2 scored 1 or more SD below the
mean for sustained attention, auditory slective attention, and auditory verbal working memory.
Results of the Elevator Counting subtest varied from pre-treatment to post-treatment to followup, dropping from 10 to 4 and returning ultimately to 10. Lottery results improved steadily from
pre-treatment to post-treatment, going from 6 to 8 to 13 at each phase. Combined results of both
Elevator Counting and Lottery subtests suggest that sustianed attention improved, or at least
remained stable throughout treatment. Results for the Map Search remained steady from pretreatment to post-treatment at 7, but dropped at follow-up to 5. The Telephone Search subtest
dropped from 7 at pre-treatment to 4 at post-treatment where it remained at follow-up. Given the
results for these two subtests, no real improvement for selective attention can be gleaned from
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treatment. Visual Elevator and Telephone Search Counting both remained within 1 SD below the
mean or 1 or more SDs above the mean throughout A1-A2-A3 phases indicating that particpant 2
maintained strenghts in alternating attention throughout treament.
APT-II Attention Questionnaire pre-treatment results showed a little-mild disruption on
ADLs. Particpant 2’s APT-II Attention Questionnaire response increased at post-treament to 15
from 12 at pre-treatment, indicating a change from little-mild interuption of ADLs to a moderate
disruption. At follow-up, however, her score dropped down to a 6, putting her back in the littlemild disruption category and indicating that the effects of attention deficits on daily functionig
had decreased considerably from pre-treatment.
Q3. Improvement was seen on the SJS for participant 2 from pre-treatment to posttreatment and this improvement remained at follow-up. Particpant 2 scord 3.5 at pre-treatment
and 4 at both post-treatment and follow-up. Refer to Appendix D for all results.
Q4. At the onset of treatment, participant 2 identified 2 functional goals that she
addressed throughout the treatment. They were to consistently maintain the topic in a five minute
conversation and to attend consistently to a 5-10 minute monologue such as a presentation in her
bible study group. Participant 2 first focused on noticing moments where her attention would
drift, and then bringing it back to the conversation or monologue. For the conversational goal she
would try to repair the communication breakdown by asking for clarification. She reported
steady improvement in both goals and reported being able to attend most of the time to 5-7
minute conversations and 10-15 minutes monologues by the end of treatment. Feedback from
participant 2’s daughter supported her progress reports. By the end of treatment, participant 2
had met both of her functional goals. See Table 4 below for participant 2’s goals and outcomes.
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Table 4. Participant 2 summary of functional goal progress.
Functional Goal
1. Participant will maintain
topic in a 5 minute
conversation by cueing
self to “tune in” and
asking for clarification
when needed.
2. Participant will be able to
consistently attend to a 5
to 10 minute monologue
(in-person, on TV, etc.)
by cueing self to “tune
in”.

Pre-treatment Rating and
Interpretation
-2
Able to maintain the topic in
2/5 5-minute conversations
but will forget to “tune in”
and ask for clarification.

Post-treatment Rating and
Interpretation
+1
Able to maintain topic in 5/5
5-minute conversations by
cueing self to “tune in” and
asking for clarification.

-2
Able to attend to less than a
5 minute monologue and not
cueing self to “tune in”.

+1
Able to attend to a 10
minute monologue by
cueing self to “tune in”.

3.3 Participant 3
Unlike participants 1 and 2, participant 3 was only administered the slow version of all
tasks. Because she excelled on all initial trails of each task, achieving between 96-100% in the
first two treatment sessions, she was not required to duplicate her performance to increase
complexity. When she did score below advancement criteria in two consecutive presentations of
a novel task in her third treatment session, she was required to achieve criteria on her previously
mastered task before again attempting to increase complexity. Participant 3 used similar
metacognitive strategies as described above, including identifying aspects of task difficulty,
predicting difficulty prior to beginning a new task, and repeating instructions subvocally. She
also used the breathing and postural techniques which included taking 10 deep breaths before
beginning training on APT-III tasks, using “body alert” posture (an APT-III term) which
involved sitting comfortably with a straight back and with the body oriented directly forward
toward the computer screen.
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Q1. All judges agreed that Participants 3 had stable baselines in her treated domains prior
to commencing APT-III treatment. Particpant 3 began treament in the domain of selective
attention. No agreement was found between judges in this domain. Working memory was judged
improved by all judges between A1-A2 and A1-A3. Suppression was judged as constant in the A2A2 phase, improved between A1-A3 by judges 1 and 2, and improved by all judges between A2A3. Alternating attention was judged constant between A1-A2 and decreasing between A2-A3.
Sustained attention was also judged as decreasing between A2-A3. Below are the graphs used
during visual analysis.
Effect size calculations for working memory and suppression showed the most consistent
improvement for participant 3. From post-treatment to follow-up, she maintained a positive
medium effect size for working memory and moved from a medium to quite large effect size for
suppression. The domain of alternating attention proved variable from one analyses to the next,
but always remained negative. Selective attention displayed a slight decrease in performance
from post-treatment to follow-up, going from a large effect size to a medium effect size.
Sustained attention also decreased from post-treatment to follow-up, going from a small negative
effect size to a large negative effect size. In summary for participant 3, improvments in
performance were found for the untrained domains of working memory and suppression at both
post-treatment and follow-up.
Q2. Pre-treament result of the CPT-II indicate a CI score of 83.9, meaning there was a
83.9/100 chance that a significant attention impairment was present. CPT-II CI scores showed a
steady improvement from pre-treatment to post-treatment and again to follow-up, indicating that
participant 3 had a decreasing attentional impairment at each phase of treatment. At posttreatment, participant 3’s CI score had dropped to 70.07 and by follow-up it was 65.14. Although
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partipant 3 never made it out of the range of severe attentional impairment (CI <60), she
continuously brought her attention closer to the range of functional limits.
More specifically, CPT-II results showed improvement for hit reaction time block change
from poor vigilance at pre-treatment and post-treatemnt to within normal limits at follow-up,
and for hit standard error block change from poor vigilance at pre-treatment to within normal
limits at post-treatment and follow-up. Variability t-scores also improved from inattention at pretreatment to within normal limits at post-treatment and at follow-up. Hit reaction time, hit
reaction time standard error, response style and perserverations were all variable from A 1 to A2
to A3. Perseverations t-scores dropped to the level of impulsive at post-treatment from within
normal limits at pre-treatment, but returned to within normal limits at follow-up. Hit reaction
time, hit reaction time standard error, and response style all showed the opposite pattern,
improving at post-treatment only to return to their pre-treatment levels at post-treatment. Refer
to Appendix D for all secondary outcome results.
Pre-treatment TEA scores indicated that participant 3 scored 1 or more SDs below the
mean for selective attention only. TEA results were the same across phases for Elevator
Counting and remained within 1 SD above or below the mean for the Lottery subtest. These
combined results indicate that sustained attention abilities remained about the same throughout
treatment. The Telephone Search subtest showed a steady decline in scores from A1 to A2 to A3.
The Map Search subtest score remained extremely low from pre-treatment to post-treatment and
could not be tested at follow-up due to participant health. The Telephone Search Couting subtest
scores remained fairly steady from phase to phase, indicating no real change in alternating
attention. The Elevator Couting with Distractions subtest decreased steadily from A1-A2-A3,
suggesting a progressively decreased performance in working memory.
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Results of the APT-II Attention Questionnaire indicate that particpant 3’s attentional
deficits caused a severe disruption to her ADLs throughout treatment. Her scores varied little at
each phase, going from 29 at pre-treatment to 26 at post-treatment and back to 29 at follow-up.
Q3. Compared to participants 1 and 2, results of the SJS were more variable for
participant 3 who scored 3.5 at pre-treatment, 3 at post-treatment, and 3.5 again at follow-up.
Refer to Appendix D for all results.
Q4. The two goals that participant 3 decided upon were to maintain the topic in a 7
minute conversation and to summarize the most important details of the latest chapter she’d read
in a novel. The first goal was reported on regularly with participant 3 indicating steady
improvement over the course of treatment. The second goal identified by participant 3 was not
addressed until mid-treatment due to participant illness, family emergency, and other
complications. However, by the time it was addressed, participant 3 made notable progress in
succinctly summarizing what she had read with details sufficient to elucidate the plot to the
research assistant who was otherwise unfamiliar with the novel. Participant 3 clearly felt that she
had made progress on her conversational goal and was able to meet her second goal of
summarizing a novel chapter, but only with considerable cueing in the form of questions from
the research assistant. Refer to Table 5 below for participant 3’s goals and outcomes.
Table 5. Participant 3 summary of functional goal progress.
Functional Goal
1. Participant will maintain
topic in a 7 minute
conversation by cueing
self to “tune in” and
asking for clarification
when needed.

Pre-treatment Rating and
Interpretation
-2
Able to maintain the topic in
3 a minute conversation but
forgets to “tune in” and ask
for clarification when
needed.
35

Post-treatment Rating and
Interpretation
+1
Able to maintain the topic in
a 10 minute conversation by
cueing self to “tune in” and
asking for clarification when
needed.

Table 5. continued
Functional Goal
2. Participant will be
accurately summarize
the main plot points of
the most recent chapter
of a novel she has read
by reminding herself to
pay attention while
reading.

Pre-treatment Rating and
Interpretation
-2
Able to summarize each
chapter read with 50%
accuracy.
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Post-treatment Rating and
Interpretation
+2
Able to summarize each
chapter read with 100%
accuracy. *moderate cueing
was required on the part of
the research assistant to
achieve this level of
accuracy

CHAPTER 4. DISCUSSION
Overall, the APT-III treatment resulted in improvement in both treated and untreated
attentional domains. Results of secondary outcome measures designed to identify changes in
impairment, activity, and participation levels were variable across participants. Working memory
as measured by the SJS task showed that all participants began and remained within normal
limits for healthy controls their age (i.e. could manipulate 3-4 items). Participants all made
progress on functional goals addressed through goal attainment scaling. The theoretical, clinical
and research implications of these findings will be presented in the following sections, as will
limitations and future research. However, since each participant serves as his or her own control
in SCED, the discussion begins with how individual participants with PD responded to the
treatment.
4.1 Participant 1
Participant 1 was a 72 year-old former professional, 6 years post PD diagnosis with a
Hoehn & Yahr severity score of 2. In regards to our first experimental question, improvements
were noted in the untrained domains of working memory, suppression, and alternating attention
but not the trained domain (sustained attention). For working memory, this included a very large
effect size at post-treatment and an even larger effect size at follow-up. Suppression showed yet
larger effect sizes at post-treatment and follow-up. Alternating attention showed more modest
but nonetheless significant improvement with a medium post-treatment effect size and a small to
medium effect size at follow-up. Inspection of the sustained attention probe data suggest that
possible improvements noted in participant 1’s successful mastery of the computerized sustained
attention tasks may have been lost because the probe did not measure what was being trained, as
it was intended to do.
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On the CPT-II, participant 1 maintained a clinical impairment score of 50 at all phases.
While this score did not indicate a significant attentional impairment, individual subscores for
response style, a correalte to suppression in the APT-III hierarchy, indicated that participant 1
consistently improved from A1-A2 and A2-A3. This improvement supports the increasingly large
effect sizes in the suppression domain from A2 to A3.
On the TEA, participant 1’s results also showed consistent performance on sustained
attention activities (Elevator Counting and Lottery) and improved performance on selective
attention (Telephone Search) at A3.
The APT-II Attention Questionnaire, indicated that participant 1 continuously decreased
the level of impairment on his ADLs from severe at pre-treatment to moderate at post-treatment
and little-mild at follow-up. Likewise, participant 1 reported consistent improvement on his
functional goals, suggesting that direct attention training may have generalized and made an
impact on his everyday life.
The SJS task results showed that participant 1 was within funcional limits for adults his
age, remaining 1 SD above or below the mean at each phase. While always within 1 SD of the
mean, participant 1 improved his SJS performance from pre-treatment to post-treatment and this
improvement remained at follow-up. This upward trend supports the very large effect sizes seen
for working memory at A2 and A3.
4.2 Participant 2
Participant 2 was a 70 year-old former professional, 10 years post PD diagnosis with a
Hoehn & Yahr severity score of 3. For participant 2, treatment effects were found at follow-up
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for sustained attention (trained) and working memory (untrained). Also at follow-up, sustained
attention and working memory both showed small effect sizes.
On the CPT-II, particpant 2 showed a consistent decline on CI score. However, TEA
results showed functional gains in sustained attention (Lottery subtest). Results of the APT-II
Attention Questionnaire showed fairly consistent results at A1 and A2, staying near the cusp of
little-mild to moderate impairment. At follow-up, however, her score dropped well within the
category of little-mild impairment.
SJS results showed that participant 2 was within functional limits for adults her age,
remaining within 1 SD above or below the mean at each phase, but improving her performance
at both A2 and A3. This improvement pattern aligns with the effect size in working memory at
the A3 phase. Participant 2 met both her functional goals addressed through GAS, indicating
successful generalization of attentional gains to ADLs.
4.3 Participant 3
Participant 3 was a 69 year-old former professional, 11 years post PD diagnosis with a
Hoehn & Yahr severity score of 3. Over the course of treatment, participant 3 experienced
several personal setbacks that likely influenced her performance both in treatment and on
secondary outcomes measures. Foremost was a change in PD medication halfway through
treatment that made her elligible for disqualification from the study. Because of her high level of
motivation to complete the treatment, she was allowed to remain in the study. Treatment effects
were found at both post-treatment and follow-up for working memory and sustained attention.
Working memory showed the medium effect size at post-treatement and a small-medium effect
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size at follow-up. Suppression showed a small to medium effect size at post-treatment and a very
large effect size at follow-up.
On the CPT-II, particpant 3 consistently reduced her CI score. While it never dropped
below the cutoff for severe attentional impairment, her level of impairment clearly dropped. On
the TEA, participant 3 showed consistent performance on all sustained attention tasks (Lottery,
Elevator, and Telephone Search). Her participation impairment as measured by the APT-II
Attention Questionnaire remained roughly the same through all phases, never dropping below
the severe category.
SJS results showed that participant 3 was within functional limits for adults her age,
remaining less than 1 SD below the mean at each phase. For working memory, participant 3 also
showed medium and small effect sizes at post-treatment and follow-up respectively, supporting
the high level of performance seen on the SJS. Like participants 1 and 2, participant 3 met her
functional goals, indicating successful generalization of trained attentional skills.
In summary, effect sizes were found for each participant in at least two attentional
domains, although not always the trained domains. All participants showed improvments in
multiple subcategories of the CPT-II and at least 1 attentional domain measured on the TEA. For
participants 1 and 2, the APT-II Attention Questionnaire indicated significant decreases in the
effect of attentional deficits on ADLs by follow-up. All particpants remained within 1 SD of the
mean for healthy controls their age on the SJS, and participants 1 and 2 improved their scores
from pre-treatment. These results across participants suggest that these participants with PD were
able to improve their attentional performance in the impairment, activity, and participation
domains of the ICF model, and maintain gains one-month post-treatment. These results add an
important piece of information to the APT literature, where no investigators have demonstrated
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improvement in attentional processes in a group with degenerative neurological disease
previously.
The results of this study suggest that direct attention training using APT-III can improve
attention in PPD, and that these improvements appear to generalize to increased performance on
ADLs and other functional activities. Further, it suggests that PPD may benefit from future
research investigating the use of APT-III. In doing so, attention should be paid to using primary
outcome measures that are adequately sensitive to small increments of improvement and
secondary outcome measures that equate closely with the attentional domains measured on the
APT-III for participants in the age group studied.
4.4 Theoretical Implications
The results of our study suggest that training attentional deficits in PPD using APT-III is
effective in reducing impairment, improving activity, and increasing participation in the realms
of attention and working memory. As described in the literature review, the depletion of dopamine
in the basal ganglia contributes to the cognitive deficits in PD by preventing effective
communication between this deep brain structure and cortical structures via frontostriatal loops
(Nieoullon, 2002; Owen, 2004; Zgaljardic et al., 2006). Our results now suggest that attention can
be improved in a small group of participants with PD who are stable on their PD medications.
The best way to test whether dopamine plays a role in attention training would be to train
participants on and off of their PD medications. However, it seems unlikely many PPD would
participate in such a study. Another possibility could be to use neuroimaging to support changes
after treatment in the frontalstriatal loops discussed earlier.
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4.5 Clinical Implications
Like Molhman & Chazin’s 2011 findings for APT-II, we found that APT-III is a feasible
treatment for PPD. Participants were able to complete all APT-III activities with the use of
metacognitive strategies. While the APT-III protocol was challenging for particpants, the
treatment dose of two 1 hour sessions per week did not produce excessive fatigue and
participants reported enjoying the training and feeling a sense of accomplishment after
completing more difficult tasks.
Metacognitve strategies were used in APT-III training but their use did not appear to
generalize well, even in the somewhat similar post-treatment and follow-up assessment tasks.
These strategies were included in training not only to help participants compensate for their
attentional deficts and on APT-III tasks, but also to help them compensate in everyday settings
outside of treatment. However, based on lack of generalization, clinicians may have to train the
use of metacognitive strategies more explicitely.
Metacognitive strategy use extended attention training from treating only the impairment
level to treating the activity and participation levels as well. Future studies would benefit from
more actively training participants to use these strategies in a variety of settings. For example,
one strategy all particpants utilized was summarizing the directions of each new APT-III task
before beginning that task. This strategy was chosen because it gave particpants a way to monitor
their understanding of the task and ask for repetition of the directions if necessary. This
metacgonitve strategy could have easily been used prior to post-treatment and follow-up
assessment measures for the same purpose. Likewise, this strategy could be used at any time the
participant was faced with novel directions. However, it appeared that by the end of the study,
participants almost exclusively associated their metacognitive strategies with APT-III training
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exercises. While metacognitive strategy use may not have generalized as well as hoped,
participants did appear to generalize trained attentional skills as evidenced by the progress they
made toward functional goals. All three participants reported steady, satisfactory progress on
their goals over the course of treatment.
4.6 Research Implications
One specific area that deserves to be addressed is the adequacy of the probes used in this
study. As stated above, all participants were able to move through the hierarchy of APT-III tasks
for the attentional domain in which they were trained. When more difficult tasks were
encountered, metacognitive strategies were employed to help participants perservere and
participants always managed to do so. This continuous progress was not reflected in the results
of treatment probes. Rather, performance on probes proved for the most part highly variable.
Despite reviewing the data for any pattern that may have contributed to these ups and downs,
such as cognitive fatigue caused by more difficult training sessions, no convincing causal pattern
was found. As a result, we propose that the probes, which were based on the most difficult task
in each attentional domain, did not adequately reflect the smaller increments of learning that
participants achieved over the course of training and maintained into post-treatment and followup. Future experiments would benefit from probes designed to reflect attentional demands
commensurate with lower difficulty levels for the trained domain to more accurately capture
progress. This might take the form of probes that increase in difficulty as participants move up
the APT-III hierarchy.
As part of pre-treatment screening, all participants were administered the Mental Fatigue
Scale (MFS), a valid and reliable measure used to quantify the energy output required in daily
tasks among those with traumatic brian injury or other neurological disease such as PD
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(Johansson & Ronnback, 2014). The MFS has a cutoff score of 10.5, meaning that above this
score, mental faituge is present and affecting performance of ADLs. All participants were well
above this cutoff with participant 1 scoring 18.5, participant 2 scoring 14.5, and participant 3
scoring 22. Factoring in mental fatigue may provide an explanation for the variable performance
on treatment probes collected at the conclusion of each session. If training tasks were more
difficult for participants on a given day, this was likely reflected in poor perfomance on probes.
One way to avoid the affects of mental fatigue on probe results in the future might be to
administer probes prior to treatment in each session.
4.7 Limitations
The results of this study cannot be generalized to the broader PD population due to its
small sample size. Additionally, the participants were recruited from a PD support group where
members are actively encouraged to participate in research toward improving the quality of life
for those with PD. Therefore the motivation to persevere and dedicate the time necessary to
complete the study demonstrated by these three participants may not be typical in a broader PD
sample.
Participants 1 and 2 maintained pre-treatment inclusion criteria status throughout the
study, including stable medication cycles and no significant changes to their pre-treatment status.
On the other hand, participant 3 changed medications halfway through treatment and also
experienced a constellation of personal setbacks that likely constributed to the high degree of
variability in both her primary and secondary outcome measures. Nonetheless, we elected to
keep participant 3 in the study because of her enthusiasm to finish the treatment.
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As discussed under research implications, the probes used in this study were not
reflective of the day to day progress participants made in APT-III treatment. While effect sizes
were found for some attentional domains for each participants, it is likely that more sensitive
probes would have generated a greater number and/or higher degree of treatment effects.
4.8 Future Research
To test the theory that lack of dopamine in the frontostriatal loops leads to the cognitive
deficits in PD would require training individuals on and off their medications, which was
discussed above. It is possible that in the future, neuroimaging will be refined to the point that a
a neurotransmitter’s effect on a specific pathway could be identified, but that type of imaging is
not available to us at this time. Until then, using designs such as the one presented here will
have to suffice. However this study’s results are based on a very small, select group of
participants. Therefore replicating this study with a larger group of participants must be done.
Second, cognitive decline is present in about one third of newly diagnosed PD patients
and this number increases to more than half of patients within the first five years following
diagnosis (Toma & Mihancea, 2014). Providing direct attention training early after PD onset,
while participants still have relatively low impairment due to PD (i.e. Hoehn and Yahr scores of
1 or 2) may increase the duration of their independence and participation in ADLs, consequently
decreasing the mental, emotional, and financial toll on PPD, their caregivers, and society.
Third, visual analysis for this study was carried out by having untrained judges determine
the stability of baselines and the trend from phase to phase. According to Fisher, Kelley, and
Lomas in 2003, using judges trained in visual analysis tends to yield more accurate results. They
also advocate the use of trend lines in visual analysis graphs to assist judges in determining trend
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when it is unclear (Fisher, Kelley & Lomas, 2003). The use of trained judges and trend lines in
future studies would likely decrease the instances of disagreement found between visual analysis
results and effect size calculations, of which there were a handful.
Fourth, concerning secondary outcome measures, it became clear that CPT-II results
were not clinically sensitive to self-report attentional problems provided by participants, calling
into question the ecological validity of this measure for the purposes of this study. Future studies
would benefit from finding or developing a more sensitve measure of attention impairment in
PPD rather than relying on existing neuropsychological assessments that have not included this
population. For the TEA, several subtests required faster processing times than these three
participants had. Therefore, several tasks could not be completed by participants (as denoted in
Appendix D). Slowed processing times were reflected in treatement by the increased difficulty
participants had moving from the slow version of a task to the fast version, typically requiring
multiple trials on the fast version to meet criteria. Future studies might benefit from finding an
activity level measure that allows for processing time requirements of individuals with PD.
4.9 Conclusion
This study sought to determine the presence and degree of change direct attention
training using the APT-III could make in PPD. Effect sizes were found for all participants and
the largest effect sizes were reinforced by results of visual analysis. Secondary outcome
measures also indicated improvement within the ICF domains of impairment, activity, and
participation for all participants. From a clinical standpoint, this study supported the literature
indicating the feasibility of using APT-III on people with PD. These findings are very
preliminary and must be studied systematically to establish the evidence for direct attention
training in PPD.
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APPENDIX A: ATTENTIONAL PROBES
All probes were modeled after the most difficult task for each attention domain in APT-III (Sohlberg &
Mateer, 2010; Ourso, 2015).
I.

Sustained Attention:
o Directions: The participant will see a series of slides, each with either a face or an
emotion word. The participant will press a button each time he sees a word that matches
the emotion of the face from the previous slide.
o Description: Five faces with corresponding emotion words are possible – happy, sad,
angry, tired, or surprised. During the instructions, all five faces are presented. A slide
with one face will be presented, followed by another slide with one emotion word. If the
word matches the face, the participant responds by clicking a button. If the word does not
match the face, no action is taken.

II. Selective Attention:
o Directions: The participant will see a series of slides, each showing a face or an emotion
word. The participant will press a button each time he sees a word that matches the
emotion of the face from the previous slide.
o Description: This task is presented similarly to the Matching Faces and Emotion Words
task for sustained attention (a face is presented followed by a word; if the emotion word
matches the face, the participant responds). However, a distracter is also presented with
the task. An additional face is presented to the side of a box which contains the target
information.
III. Working Memory:
o Directions: The participant will see a clinician reading a series of 6-word sentences, one
at a time. The participant will manipulate each sentence and say the answer out loud. The
participant’s answer will be scored by the investigator.
 Progressive word order – the participant will say the words of the sentence in
ascending order, by the number of letters in each word. Words that have the same
number of letters will be ordered alphabetically (e.g., The black dog is very big. > is big dog the very black)
o Description: For this task, a speaker appears on-screen and reads the sentence aloud. The
participant is to order the words appropriately (as described above) and state the answer
out loud. The investigator clicks a button to move on to the next sentence.
IV. Suppression:
o Directions: The participant will see a series of slides with two words on each slide. The
words “up” “down” “forward” “backward” or “diagonal” will appear on the left side of
each screen. On the right side of each screen will be a second word written in one of the
five named directions. The participant will press a button when the direction of the
writing of the word on the right side matches the actual word on the left side of the
screen.
o Description: Both words that appear on the screen are one of the five direction words.
The word on the left is printed normally, and states the direction the participant is looking
for. The word on the right is written to demonstrate one of the different directions. The
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participant is to press the response button when the written direction demonstrated by the
word on the right matches the direction word on the left.
V. Alternating Attention:
o Directions: The participant will see a series of slides with two words on each slide. The
words “up” “down” “forward” “backward” or “diagonal” will appear on the left side of
each screen. On the right side of each screen will be a second word written in one of the
five named directions. The participant will press a button when the actual word on the left
matches or does not match the direction of the word on the right.
o Description: Both words that appear on the screen are one of the five direction words.
The word of the left is printed normally, and states the direction the participant is looking
for, while the word on the right is written to demonstrate one of the different directions.
The participant begins the task by pressing the button when the written direction
demonstrated by the word on the right matches the direction word on the left. After five
sets, the investigator will say the word “switch”. The client is then to click the button
when the written direction demonstrated by the word on the right DOES NOT match the
direction word on the left.
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APPENDIX B: METACOGNITIVE STRATEGIES
Metacognitive strategies assist with the need to self-regulate and think about one’s own thinking. They
enhance self-awareness (Ourso, 2015).

According to Sohlberg & Mateer (2010) strategy instruction may include:
 Education regarding attention strengths and weaknesses
 Better self-awareness of attention deficits to facilitate improved self-monitoring and regulation
 Selection and use of strategies designed to facilitate task completion and increase motivation
Strategies suggested in the APT-III Manual and used in this study include:
o
o
o
o
o
o
o

Pacing, taking breaks
Body alert (sitting up straight, facing the computer screen)
Working toward a goal (e.g. setting a task objective; trying to beat a score)
Breathing, relaxation techniques
Reviewing previous performance
Predict easy/hard task components
Repeat instructions (Sohlberg & Mateer, 2010, pp. 23)
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APPENDIX C: GOAL ATTAINMENT SCALING
Goal Attainment Scaling (GAS) Examples (Sohlberg & Mateer, 2010; Ourso, 2015)

Participant: _____________________________________
Date: _____________________________________________Session #: ___________________

Participant will be able to maintain attention long enough to complete a five minute
conversation without forgetting the topic of the conversation.
The participant will:
+2
Use strategies to complete conversation and rarely need to self-cue to maintain
attention. (not everyday, on some days)
+1
Use strategies to complete conversation and occasionally need to self-cue to
maintain attention. (>3 times, every day)
0
Use strategies to complete conversation and sometimes need to self-cue to
maintain attention. (1-3 times, every day)
-1
Frequently forget topic and frequently need to self-cue to maintain attention.
(Multiple times, every day)
-2
Always forget topic and always need to self-cue to maintain attention. (Every
time, every day)

Participant will use a key hook and attend to placing his keys on the hook each time
he enters his home, reducing the number of times he cannot locate his keys. The
participant will:
+2
Use the key hook most of the time and rarely misplace his keys.
+1
Use the key hook sometimes and sometimes misplace his keys.
0
Use the key hook 5-6 times per week and occasionally misplace his keys.
-1
Use the key hook 3-4 times per week and often misplace his keys.
-2
Not use the key hook multiple times per week and frequently misplace his keys.
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APPENDIX D: SECONDARY OUTCOME MEASURES
Secondary Outcome Measures for all Participants at 3 time points
Participant 1
Connors' Continuous Performance Test II (CPT II v.5)
Pre-treatment
Post-treatment
TMeasures
Score
Interpretation
Clinical Profile CI **= 50
Omissions
Hit RT
Hit RT se
Variability
Response
Style

46.05
57.68
51.39
38.19

Perseverations
Hit RT Block
Chg
Hit se Block
Chg

30.13

OK
OK
OK
OK
Markedly
atypical
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OK

48.87

OK

55.8

OK

TMeasures
Score*
Interpretation
Clinical Profile CI **= 50
Omissions
Hit RT
Hit RT se
Variability
Response
Style
Perseverations
Hit RT Block
Chg
Hit se Block
Chg

61.43
58.48
55.13
54.82

Inattention
Inattention
OK
OK

62.11

Mildly atypical
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OK

43.81

OK

48.12

OK

TMeasures
Score
Interpretation
Clinical Profile CI **= 50
Omissions
Hit RT
Hit RT se
Variability
Response
Style

42.97
58.34
49.07
35.65

OK
Inattention
Inattention
OK

47.53

Average range

Perseverations
Hit RT Block
Chg
Hit se Block
Chg

42.49

OK

39.05

OK

48.33

OK

Participant 2
Connors' Continuous Performance Test II (CPT II v.5)
Pre-treatment
Post-treatment
TMeasures
Score Interpretation
Clinical Profile CI **= 55.54
Omissions
Hit RT
Hit RT se
Variability

85.11
81.49
64.3
63.03

Response Style
Perseverations
Hit RT Block
Chg
Hit se Block
Chg

73.1
80.62

Inattention
Inattention
Inattention
Inattention
Markedly
atypical
Impulsive

54.29

OK

45.26

OK

TMeasures
Score* Interpretation
Clinical Profile CI **= 57.13
Omissions
Hit RT
Hit RT se
Variability

52.9
84.54
58.69
36.93

OK
Inattention
Inattention
OK

Response Style
Perseverations
Hit RT Block
Chg
Hit se Block
Chg

61.5
45.52

Mildly atypical
OK

50.58

OK

46.45

OK

Follow-up

Follow-up

TMeasures
Score Interpretation
Clinical Profile CI **= 73.39
Omissions
Hit RT
Hit RT se
Variability

47.93
87.9
64.14
46.6

OK
Inattention
Inattention
OK

Response Style
Perseverations
Hit RT Block
Chg
Hit se Block
Chg

39.39
45.52

Mildly atypical
OK

60.1

poor vigilance

58.1

poor vigilance

Participant 3
Connors' Continuous Performance Test II (CPT II v.5)
Pre-treatment
Post-treatment
TMeasures
Score
Interpretation
Clinical Profile CI **= 83.9
Omissions
Hit RT
Hit RT se
Variability
Response Style

55.53
69.88
68.64
59.73
39.39

OK
Inattention
Inattention
Inattention
mildly atypical

Perseverations
Hit RT Block
Chg
Hit se Block
Chg

45.52
58.47

OK
poor vigilance

69.36

poor vigilance

TMeasures
Score*
Interpretation
Clinical Profile CI **= 70.07
Omissions
Hit RT
Hit RT se
Variability
Response
Style
Perseverations
Hit RT Block
Chg
Hit se Block
Chg

47.93
56.88
57.18
48.12
45.87
63.07
62.57
55.96
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OK
OK
OK
OK
average
range
Impulsive
poor
vigilance
OK

Follow-up

TInterpretatio
Measures
Score
n
Clinical Profile CI **= 65.14
Omissions
Hit RT
Hit RT se
Variability
Response Style

47.93
63.62
63.66
55.43
43.53

Perseverations
Hit RT Block
Chg
Hit se Block
Chg

45.52
47.54

OK
Inattention
Inattention
OK
mildly
atypical
OK
OK

51.78

OK

Secondary Outcome Measures for all Participants at 3 time points (continued)
Participant 1
Test of Everyday Attention
Post-treatment

Pre-treatment
Factor/Subtest
Visual Selective
attention/speed

Scaled Scores
(M=10 SD±3)

Follow-up

Scaled Scores
(M=10 SD±3)

Factor/Subtest
Visual Selective
attention/speed

Factor/Subtest
Visual Selective
attention/speed

Scaled Scores
(M=10 SD±3)

Map Search

6

Map Search

4

Map Search

3

Telephone Search

5

Telephone Search

4

Telephone Search

9

Attentional Switching
Visual Elevator (#
correct)

Attentional Switching
CNC***

Visual Elevator

Sustained Attention
13
10
2

CNC***
13

Visual Elevator

Lottery

8

Elevator Counting
Telephone Search
Count.
Auditory/Visual
Working Memory
Elevator Counting
Rev.
Elevator Counting
Dist.

Scaled Scores
(M=10 SD±3)

10
6

CNC***
5

Lottery

13

Elevator Counting
Telephone Search
Count.
Auditory/Visual
Working Memory
Elevator Counting
Rev.
Elevator Counting
Dist.

10
2

CNC***
10

Follow-up

Scaled Scores
(M=10 SD±3)

Factor/Subtest
Visual Selective
attention/speed

CNC***

Sustained Attention

Participant 2
Test of Everyday Attention
Post-treatment

Pre-treatment
Factor/Subtest
Visual Selective
attention/speed

CNC***

Sustained Attention

Lottery
Elevator Counting
Telephone Search
Count.
Auditory/Visual
Working Memory
Elevator Counting
Rev.
Elevator Counting
Dist.

Attentional Switching

Factor/Subtest
Visual Selective
attention/speed

Scaled Scores
(M=10 SD±3)

Map Search

7

Map Search

7

Map Search

5

Telephone Search

7

Telephone Search

4

Telephone Search

4

Attentional Switching
Visual Elevator (#
correct)

Attentional Switching
11

Sustained Attention

Visual Elevator

7

Sustained Attention

Lottery
Elevator Counting
Telephone Search
Count.
Auditory/Visual
Working Memory
Elevator Counting
Rev.
Elevator Counting
Dist.

Attentional Switching

6
10
15

CNC***
6

8
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11

Sustained Attention

Lottery
Elevator Counting
Telephone Search
Count.
Auditory/Visual
Working Memory
Elevator Counting
Rev.
Elevator Counting
Dist.

Visual Elevator

4
11

CNC**
CNC**

Lottery
Elevator Counting
Telephone Search
Count.
Auditory/Visual
Working Memory
Elevator Counting
Rev.
Elevator Counting
Dist.

13
10
8

CNC***
CNC***

Secondary Outcome Measures for all Participants at 3 time points (continued)
Participant 3
Test of Everyday Attention
Post-treatment

Pre-treatment
Factor/Subtest
Visual Selective
attention/speed
Map Search

Scaled Scores
(M=10 SD±3)

Map Search
7

Attentional Switching
Visual Elevator

<3

Telephone Search

CNC***

Visual Elevator

2

13
10
8

CNC***
7

Map Search

CNC***

Telephone Search

<1

Attentional Switching
CNC***

Visual Elevator

Sustained Attention

Lottery

Scaled Scores
(M=10 SD±3)

Factor/Subtest
Visual Selective
attention/speed

Attentional Switching

Sustained Attention

Elevator Counting
Telephone Search
Count.
Auditory/Visual
Working Memory
Elevator Counting
Rev.
Elevator Counting
Dist.

Scaled Scores
(M=10 SD±3)

Factor/Subtest
Visual Selective
attention/speed

<3

Telephone Search

Follow-up

CNC***

Sustained Attention

Lottery

13

Elevator Counting
Telephone Search
Count.
Auditory/Visual
Working Memory
Elevator Counting
Rev.
Elevator Counting
Dist.

10
6

CNC***
5

Lottery

8

Elevator Counting
Telephone Search
Count.
Auditory/Visual
Working Memory
Elevator Counting
Rev.
Elevator Counting
Dist.

10
7

CNC***
2

APT-II Attention Questionnaire
Pre-test

Post-test

Follow up

Participant 1

32

17

12

Participant 2

12

15

6

29

26

29

Participant 3

Size Judgment Span Task
Pre-test

Post-test

Follow-up

Global Index
(M=3.53 SD ±.72)

Global Index
(M=3.53 SD ±.72)

Global Index
(M=3.53 SD ±.72)

Participant 1

3.00

4.00

4.00

Participant 2

3.50

4.00

4.00

Participant 3

3.50

3.00

3.50

Note: CPT-II, (Conners, 2004); TEA, (Robertson et al., 1994); APT-II Attention Questionnaire,
(Sohlberg et al., 2001); SJS, (Cherry et al., 2007)

58

APPENDIX E: INSTITUTIONAL REVIEW BOARD APPROVAL
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